期刊文献+

Diminution of toxic copper accumulation in toxic milk mice modeling Wilson disease by embryonic hepatocyte intrasplenic transplantation 被引量:9

Diminution of toxic copper accumulation in toxic milk mice modeling Wilson disease by embryonic hepatocyte intrasplenic transplantation
下载PDF
导出
摘要 AIM: To observe the therapeutic effect of intrasplenic transplantation with embryonic hepatocytes on amelioration of hereditary copper accumulation in toxic milk (TX) mouse modeling Wilson disease. METHODS: Donor hepatocytes were harvested from 14-d fetal liver of a pregnant homogeneous DL mouse. These cells were successively cultured, labeled with fluorescein dye Hoechst 33342 for 24 h, and sequentially infused into the spleen parenchyma of the recipient TX mice. No host immunosuppression measures were taken. Two and four weeks after transplantation, the recipients were killed for routine histologic investigation and immunohistochemistry study up to 4 wk after transplantation. The serum copper and ceruloplasmin concentrations of the recipient mice were determined by graphite furnace atomic absorption spectroscopy.RESULTS: In the following 2nd and 4th wk after transplantation, the donor hepatocytes could be visualized in the livers of 47.3% recipients. The serum ceruloplasmin and copper concentrations increased by 1.6-fold after 2 wk and 2.0-fold times after 4 wk respectively, which ultimately rose from about 30% of the normal level to nearly 60%(P<0.01). The hepatic copper concentration decreased 7.2%, 4 wk after transplantation. Pathologic examination showed that there were many actively proliferative hepatocyte precursor cells with specific embryonic hepatocyte marker AFP migrated into hepatic sinusoidsof the recipients. A large number of cells carrying hepatocytes marker and albumin were observed in the recipient spleen tissues.CONCLUSION: Embryonic hepatocytes are capable of differentiating into mature hepatocytes in vivo. After transplantation, the hereditary abnormalities of copper metabolism in TX mice could be corrected partially by intrasplenic transplantation of homogeneous embryonic hepatocytes. AIM: To observe the therapeutic effect of intrasplenic transplantation with embryonic hepatocytes on amelioration of hereditary copper accumulation in toxic milk (TX) mouse modeling Wilson disease. METHODS: Donor hepatocytes were harvested from 14-d fetal liver of a pregnant homogeneous DL mouse. These cells were successively cultured, labeled with fluorescein dye Hoechst 33342 for 24 h, and sequentially infused into the spleen parenchyma of the recipient TX mice. No host immunosuppression measures were taken. Two and four weeks after transplantation, the recipients were killed for routine histologic investigation and immunohistochemistry study up to 4 wk after transplantation. The serum copper and ceruloplasmin concentrations of the recipient mice were determined by graphite furnace atomic absorption spectroscopy. RESULTS: In the following 2nd and 4th wk after transplantation, the donor hepatocytes could be visualized in the livers of 47.3% recipients. The serum ceruloplasmin and copper concentrations increased by 1.6-fold after 2 wk and 2.0-fold times after 4 wk respectively, which ultimately rose from about 30% of the normal level to nearly 60% (P<0.01). The hepatic copper concentration decreased 7.2%, 4 wk after transplantation. Pathologic examination showed that there were many actively proliferative hepatocyte precursor cells with specific embryonic hepatocyte marker AFP migrated into hepatic sinusoids of the recipients. A large number of cells carrying hepatocytes marker and albumin were observed in the recipient spleen tissues. CONCLUSION: Embryonic hepatocytes are capable of differentiating into mature hepatocytes in vivo. After transplantation, the hereditary abnormalities of copper metabolism in TX mice could be corrected partially by intrasplenic transplantation of homogeneous embryonic hepatocytes.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第24期3691-3695,共5页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China, No. 30400147211 Project of Sun Yat-Sen University, No. 98138and the Key Subject Support Grants from Ministry of Public Health No. 2001321
关键词 铜中毒 小鼠 动物实验 胚胎肝细胞 脾脏移植 Transplantation Wilson disease Copper Ceruloplasmin
  • 相关文献

参考文献21

  • 1[1]Prashanth LK,Taly AB,Sinha S,Arun odaya GR,Swamy HS.Wilson's disease:diagnostic errors and clinical implications.J Neurol Neurosurg Psychiatry 2004; 75:907-909
  • 2[2]Jablonska KI,Droblnska JA,Dabrowska E,Trocha H.Results of treatment of Wilson's disease-own observations.Med Sci Monit 2003; 9(Suppl 3):9-14
  • 3[3]Ferenci P.Review article:diagnosis and current therapy of Wilson's disease.Aliment Pharmacol Ther 2004; 19:157-165
  • 4[4]Emre S,Atillasoy EO,Ozdemir S,Schilsky M,Rathna Varma CV,Thung SN,Sternlieb I,Guy SR,Sheiner PA,Schwartz ME,Miller CM.Orthotopic liver transplantation for Wilson's disease:a single-center experience.Transplantation 2001; 72:1232-1236
  • 5[5]Podgaetz E,Chan C,Liver transplant team.Liver transplantation for Wilson s disease:our experience with review of the literature.Ann Hepatol 2003; 2:131-134
  • 6[6]Hodgson H.Liver cells:biology to therapeutics.Clin Med 2003; 3:161-165
  • 7[7]Foxl IJ,Roy-Chowdhury J.Hepatocyte transplantation.J Hepatol 2004; 40:878-886
  • 8[8]Theophilos MB,Cox DW,Mercer JF.The toxic milk mouse is a murine model of Wilson disease.Hum Mol Genet 1996; 5:1619-1624
  • 9[9]Grompe M.Liver repopulation for treatment of metabolic diseases.J Inherit Metab Dis 2001; 24:231-244
  • 10[10]De Vree JM,Ottenhoff R,Bosma PJ,Smith AJ,Oude Elferink RP.Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis.Gastroenterology 2000; 119:1720-1730

同被引文献68

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部